Vildagliptin for early Parkinson's disease
Treatments studied
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests whether vildagliptin, a diabetes drug, can slow the progression of early Parkinson's disease. It is for people who have been diagnosed within the past three years and are already taking stable Parkinson's medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old.
- You have been diagnosed with Parkinson's disease within the last 3 years.
- You have been on a stable dose of your Parkinson's medications for at least 1 month.
- Your Parkinson's is not too advanced (you can walk without help and have only mild balance issues).
- You do not have diabetes or have not taken certain diabetes drugs (like GLP-1 or DPP-4 inhibitors).
- You have no significant memory or thinking problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether sitagliptin, a diabetes drug, can slow the progression of early Parkinson's disease. It aims to see if the medication can protect brain cells and reduce symptoms, potentially offering a new way to treat Parkinson's.
This trial tests a new oral medication, VG081821AC, in people with early to mid-stage Parkinson's disease. The goal is to see if it can improve movement symptoms and slow the progression of the condition, and it may offer a new treatment option for those not yet on levodopa.
This trial tests if metformin, a diabetes drug, can help people with Parkinson's disease. It may improve symptoms or slow progression.
This study tests a new once-daily pill called BHV-8000 in people who were recently diagnosed with early Parkinson's disease and are not yet on medication. The goal is to see if it can slow the progression of symptoms and improve quality of life.
This trial tests whether the anti-inflammatory drug dapansutrile can help people with early Parkinson's disease. You would get either dapansutrile or a placebo (a pill with no active drug) to see if it slows the disease.
This trial tests an investigational drug called GT-02287 in people with early-stage Parkinson's disease (diagnosed within the last 7 years). The goal is to see if it is safe and how the body processes it, with a special focus on people with certain genetic changes (GBA1 mutations) that may be linked to Parkinson's.
Hear when a new Parkinson's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.